Time to onset analysis of letrozole associated osteonecrosis of jaw in FDA adverse event reporting system (FAERS) database

被引：0
|
作者：
Viswam, Subeesh Kulangara [1 ]
Reddy, Neha [1 ]
Gouri, Nair [1 ]
Sai, Minnikanti Satya [1 ]
Kunnavil, Radhika [2 ]
Maheswari, Eswaran [1 ]
机构：
[1] MS Ramaiah Univ Appl Sci, Bangalore, Karnataka, India
[2] Ramaiah Med Coll, Bangalore, Karnataka, India
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
2328
引用
收藏
页码：460 / 460
页数：1
相关论文
共 50 条
  • [31] Carfiilzomib-induced cardiotoxicity: An analysis of the FDA Adverse Event Reporting System (FAERS)
    Buck, Benjamin
    Kellett, Eric
    Addison, Daniel
    Vallakati, Ajay
    [J]. JOURNAL OF THE SAUDI HEART ASSOCIATION, 2022, 34 (03) : 134 - 141
  • [32] Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)
    Timbrook, Tristan T.
    McKay, Lydia
    Sutton, Jesse D.
    Spivak, Emily S.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [33] The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Caruso, I.
    Di Gioia, L.
    Di Molfetta, S.
    Caporusso, M.
    Cignarelli, A.
    Sorice, G. P.
    Laviola, L.
    Giorgino, F.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024,
  • [34] Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database
    Snopek, Frank
    Seddighzadeh, Ali
    Flynn, Megan
    Cai, Ling-Yu
    Chen, Esther
    Shih, Weichung Joe
    Qin, Albert
    Urbanski, Raymond W.
    [J]. BLOOD, 2023, 142
  • [35] A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
    Zou, Fan
    Zhu, Chengyu
    Lou, Siyu
    Cui, Zhiwei
    Wang, Dan
    Ou, Yingyong
    Wang, Li
    Chen, Junyou
    Lan, Yuanbo
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [36] Real-world pharmacovigilance analysis of galsulfase: a study based on the FDA adverse event reporting system (FAERS) database
    Li, Shangze
    Huang, Runcheng
    Meng, Yuanyuan
    Liu, Yijia
    Qian, Jiao
    Zou, Junjie
    Yang, Jun
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] Severe hypoglycemia in children treated with nadolol: A case report and FDA adverse event reporting system (FAERS) database analysis
    Bergamaschi, Francesco
    Fumagalli, Mara
    Mannarino, Savina
    Carlucci, Patrizia
    Radice, Sonia
    Gringeri, Michele
    Mosini, Giulia
    Carnovale, Carla
    Battini, Vera
    Fabiano, Valentina
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 333 - 340
  • [38] The Antidepressant Effects of Hypoglycaemic Agents: New Insights from an Analysis of the FDA Adverse Event Reporting System (FAERS) Database
    Carnovale, C.
    Battini, V.
    Gringeri, M.
    Mosini, G.
    Guarnieri, G.
    Radice, S.
    Clementi, E.
    Manen, R. P. V.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1285 - 1285
  • [39] Melanoma associated with TNFa inhibitor agents in the FDA Adverse Event Reporting System (FAERS): Analysis of reported outcomes
    Nardone, Beatrice
    Bhattacharya, Tanya
    Bruins, Finola M.
    Hammel, Josh A.
    Haugh, Isabel M.
    West, Dennis P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB209 - AB209
  • [40] Exploring the Risk of Demyelination Associated with TNF Alpha Inhibitors: Analysis of the FDA Adverse Event Reporting System (FAERS)
    Sondhi, Manush
    Vyas, Rahul
    Thakre, Anuj
    Hayat, Samina
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2105 - 2106
12345